SINERGINA 100MG TABLETS

Country: Cyprus

Language: Greek

Source: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

Active ingredient:

PHENYTOIN

Available from:

FAES FARMA SA (0000002088) MAXIMO AQUIRRE 14, LEIOA(VIZCAYA), 48940

ATC code:

N03AB02

INN (International Name):

PHENYTOIN

Dosage:

100MG

Pharmaceutical form:

TABLETS

Composition:

PHENYTOIN (0000057410) 100MG

Administration route:

ORAL USE

Prescription type:

Ειδική άδεια άρθρο 126A

Therapeutic area:

PHENYTOIN

Product summary:

Νομικό καθεστώς: Με Ιατρική Συνταγή που Επαναλαμβάνεται; PACK WITH 100 TABS IN BLISTER(S) () 100 TABLET - Εγκεκριμένο - Με Ιατρική Συνταγή που Επαναλαμβάνεται

Patient Information leaflet

CODIGO ITF
40 grs.
1+1
NEGRO
148x594
148x297
HELVETICA
6 pt
6,5 pt
P.3
INTERLÍNEA
ESPACIO ENTRE LETRAS
277
Fecha 02/12/19
Fecha 02/12/19
A-A/803705 PRO SINERGINA 100 COMP CHIPRE
148 mm
PORTADA
CONTRAPORTADA
148 mm
297 mm
Ainoa
FAES FARMA
DESARROLLO INTERNO
PLEGADO EN LINEA 148X297
Líneas de plegado
Línea del siguiente plegado
1ER CUERPO
DIPTICO
WHAT IS IN THIS LEAFLET
1. What Sinergina is and what it is used for
2. What you need to know before you take Sinergina
3. How to take Sinergina
4. Possible side effects
5. How to store Sinergina
6. Contents of the pack and other information
1. WHAT SINERGINA IS AND WHAT IT IS USED FOR
Sinergina contains the active substance phenytoin.
Phenytoin belongs to the group of medicinal products called
antiepileptics, which are used to treat epilepsy.
Sinergina is indicated in the treatment of the following types
of
epilepsy:
generalised
tonic-clonic
episodes
(grand
mal
seizures) and complex partial seizures, and in the treatment
and prevention of seizures in neurosurgery.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE SINERGINA
DO NOT TAKE SINERGINA
•
if you are allergic (hypersensitive) to phenytoin or to any of the
other components of this drug (included in section 6).
•
if you are allergic to hydantoin-type medicinal products.
•
if you are taking a medicinal product called delavirdine to treat
HIV infection.
WARNINGS AND PRECAUTIONS
Talk to your doctor or pharmacist before taking Sinergina.
•
if you suffer from any liver disease or other serious illness or
are elderly. If during treatment you notice symptoms that may
indicate hepatitis, such as jaundice (yellow colouring of
the skin and of the whites of the eyes), consult your doctor
immediately,
•
if
you
have
porphyria
(a
hereditary
illness
that
affects
haemoglobin biosynthesis),
•
if you are diabetic, as phenytoin can raise glucose levels,
•
if you consume large amounts of alcohol or regularly drink
small quantities,
•
if you are receiving treatment with cranial radiotherapy or are
reducing your treatment with c